Another common use is as an adjunct in managing neuropathy due to diabetes or medication effects, when a clinician identifies or suspects a coexisting deficiency
Liraglutide vs Semaglutide: 2.5x Weight Loss Gap STEP 8 head-to-head: 15.8% vs 6.4% weight loss
Are peptide injections safe for long-term use
Semaglutide alongside hormone optimization for weight loss
Eddie Hughes, FNP-BC Eddie is a board-certified Family Nurse Practitioner with 15+ years of clinical experience spanning emergency medicine, neurosurgery, hospital medicine, and regenerative medicine
Protocol 2: significant weight loss (20-25% body weight) Goal: Substantial weight reduction for health improvement Tirzepatide approach: Full escalation to 10-15 mg Expect to reach target dose by week 17-21 Weight loss at 15 mg: approximately 22.5% at 72 weeks Plateau typically occurs around weeks 60-72 Retatrutide approach: Full escalation to 8-12 mg Expect to reach target dose by week 13-17 Weight loss at 12 mg: 24.2% at 48 weeks, 28.7% at 68 weeks No plateau observed in trial data at 48 or 68 weeks For significant weight loss goals, retatrutide reaches 20%+ body weight reduction faster and ultimately achieves a higher ceiling
)
